Search for: "JOHNSON et al v. MERCK "
Results 1 - 20
of 22
Sorted by Relevance
|
Sort by Date
District Court Invalidates Merck's Formulation Patent on Pepcid Complete, Relying on KSR v. Teleflex
6 Jun 2007, 9:00 pm
McNeil-PPC et al. v. [read post]
26 Feb 2010, 4:17 pm
Johnson & Son, Inc. et al. [read post]
20 Jan 2016, 2:39 pm
Just yesterday the Supreme Court declined to accept for hearing an appeal for the case Johnson & Johnson, et al., Petitioners v. [read post]
1 Sep 2011, 6:14 am
The claims against the remaining defendants, including Johnson & Johnson and Merck, are slated for trial starting later this year. [read post]
14 Nov 2016, 9:16 am
Petitions for Writ of Certiorari Pending: Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
8 Feb 2017, 3:09 am
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
16 Jan 2017, 5:44 pm
Amgen Inc., et al., No. 16-332 (effectively extending exclusivity to 12 1/2 years; complement to the Sandoz petition) Anticipation/Obviousness: Merck & Cie, et al. v. [read post]
28 Jun 2010, 3:08 am
Quanta Storage America, Inc. et al. [read post]
27 Jun 2010, 6:00 pm
Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
1 Nov 2010, 2:46 am
DIRECTV, Inc., et al. [read post]
9 Aug 2012, 5:00 am
Johnson & Johnson (?) [read post]
2 Mar 2012, 6:52 am
Johnson & Johnson (?) [read post]
5 Mar 2024, 10:55 am
In U.S. ex rel Adventist Health Sys., et al. v. [read post]
6 Dec 2006, 6:45 pm
Merrill et al., Eds., A Patent System for the 21st Century (National Research Council, National Academies Press, Washington, DC, 2004), pp. 25-27.What Merrill et al. said on pages 25-27 is a bit different. [read post]
24 May 2007, 10:40 am
Johnson & Johnson, 700 F. [read post]
3 Mar 2012, 6:48 am
Hoffman-LaRoche, Inc., et al., which was decided Monday. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
31 Aug 2014, 12:49 pm
In dissent in Petrella v. [read post]
4 Apr 2008, 1:00 am
, (Ars Technica), (Patent Prospector), (Washington State Patent Law Blog), (IP Law Observer), (PLI), (PLI), (IP Updates), (Patent Docs), (Peter Zura’s 271 Patent Blog), (The Invent Blog), (IP Spotlight), (Just a Patent Examiner), (Techdirt), (Patent Baristas), (IPBiz), (IPBiz), (Patently-O), (IAM), (IP ThinkTank), (Against Monopoly), (Against Monopoly), (IP Law360), (Hal Wegner), (Ladas & Parry), Global Global - General Virtual monopoly – four strategic choices:… [read post]
30 May 2008, 9:09 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: WHO members near accord on global strategy on IP and health: (Intellectual Property Watch), (GenericsWeb), (Gowlings), (IAM), Copiepresse seeks up to €49 million from Google in lawsuit over right to feature links to publishers’ content on internet: (IPKat), (Ars Technica), (Techdirt), (Out-Law), (IP Law360) Singapore ‘image… [read post]
